ECM
RMD icon

Estabrook Capital Management’s ResMed RMD Stock Holding History

Estabrook Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57K Buy
+7
New +$1.74K ﹤0.01% 356

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Estabrook Capital Management's RMD Position: Q1 2026 in Review

Estabrook Capital Management opened a new position in ResMed (RMD) in Q1 2026: 7 shares worth $1.57K. The stake represents ﹤0.01% of the portfolio and ranks #356 among its holdings.

938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Estabrook Capital Management held 7 shares of ResMed worth $1.57K as of Q1 2026.
  • ResMed was a new Estabrook Capital Management position in Q1 2026.
  • ResMed made up ﹤0.01% of Estabrook Capital Management's portfolio in Q1 2026, its #356 holding.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.